Nov 24, 2014 at 15:24 | Source: Moneycontrol.com
AstraZeneca Pharma India Ltd has informed BSE that Mr. Robert Haxton has resigned as the Wholetime Director of the Company. The Board has accepted the resignation of Mr. Haxton and that he would be relieved from the said position, effective December 14, 2014.
Nov 24, 2014 at 14:15 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Hon'ble High Court of Gujarat at Ahmedabad, at its hearing held on November 14, 2014, has sanctioned the Scheme of Arrangement in the nature of Merger of Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited.
Nov 20, 2014 at 13:47 | Source: CNBC-TV18
HB Joshipura, Managing Director of Glaxosmithkline, said parent company GSK Plc has no plans to delist it from Indian bourses.
Nov 19, 2014 at 14:39 | Source: Moneycontrol.com
Bafna Pharmaceuticals Ltd has informed BSE that CRISIL has upgraded the rating as CRISIL BB-/stable (Upgraded from CRISIL D) for Long Term rating & CRISIL A4+ (Upgraded from CRISIL D) for Short term Rating in respect of Total bank facilities.
Nov 17, 2014 at 20:49 | Source: CNBC-TV18
NSE FinWiz at GlaxoSmithKline (GSK) Pharmaceuticals, Mumbai to gauge financial planning thoughts and notions of the young employees on investments and financial planning.
Nov 14, 2014 at 19:17 | Source: CNBC-TV18
Drug makers Sun Pharma and Merck may be heading to terminate their branded generics joint venture for emerging markets, reports Archana Shukla quoting sources.
Nov 14, 2014 at 15:52 | Source: Moneycontrol.com
Aarti Drugs Ltd has informed BSE that the Board of Directors of the Company at is meeting held on November 14, 2014, has declared Interim dividend at Rs 5 (50 percent) per share for the financial year 2014- 2015.
Nov 14, 2014 at 11:05 | Source: Moneycontrol.com
Albert David Ltd has informed BSE that Mr. D. D. Binani has resigned from the Board of the Directors of the Company which has been accepted by the Board in their meeting held on November 13, 2014.
Nov 13, 2014 at 16:06 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 13, 2014, has passed the resolution approving the Scheme of Amalgamation under sections 391 to 394 of the companies Act, 1956 for Merger of Sun Pharma Global Inc into the Company.
Nov 13, 2014 at 10:36 | Source: Moneycontrol.com
Brooks Laboratories Ltd has informed BSE that Mr. Ketan Shah has resigned as the Chief Financial Officer of the Company with effect from October 09, 2014 and Mr. Anil Pillai has been appointed as the Chief Financial Officer of the Company with effect from November 01, 2014.